english.prescrire.org > Prescrire International > N°120 - October 2011

n°120

October 2011

Issue Contents
Editorial

Free  Medical incident analysis: effective teamwork is needed

p.228
Identifying preventable errors

Marketing Authorisations


Ticagrelor (New Drug)

p.229-233
Acute coronary syndromes: nothing new

Erlotinib and maintenance therapy of non-small cell lung cancer (New Indication)

p.234
Inadequate assessment, authorisation unjustified

Common stems: -caine, -cain-

p.235

Adverse Effects


Drugs used in child maltreatment

p.236-237
Difficult to recognise

Lopinavir + ritonavir oral solution: dangerous form for newborns

p.237
Regulators overlooking the formulation

Methylphenidate: growth retardation

p.238-239
Reversible

Free  Syncope with cholinesterase inhibitors

p.240
Resulting in hospital admission, hip fractures, pacemaker insertion

Proton pump inhibitors: fractures (continued)

p.241
Beware long-term use

Neuroleptics: intestinal occlusion

p.241
Antimuscarinic effects

Dronedarone: liver damage and cardiac disorders

p.241
Negative harm-benefit balance

Dasatinib: pulmonary arterial hypertension

p.241
French data

Reviews


Treatment of Parkinson's disease

p.242-245
Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment

Antiepileptic drug withdrawal in children

p.245
After at least 2 seizure-free years

Severe malaria: artesunate is now the standard treatment

p.245
In adults and children

Atrial fibrillation: strict heart rate control provides no advantage

p.246
Below 110 beats per minute is acceptable

Prevention of recurrent gastrointestinal bleeding from peptic ulcers

p.246
PPIs and Helicobacter pylori eradication

Outlook


Drug packaging

p.247-249
A key factor to be taken into account when choosing a treatment

Some frequent problems with drug packaging

p.248

Free  France's AME: medical apartheid

p.249
A major risk for the general population

Queries and comments. Trabectedin and ovarian cancer (continued)

p.249-250
Useful clarification

Free  European Medicines Agency still lags in providing key documents

p.252

Masthead


Free  Masthead

p.226

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe